SourceBio International plc (AIM: SBI), announces that admission to trading on AIM (the “Admission”) will take place and dealings will commence at 8.00 a.m. today under the ticker SBI. Read full details: ow.ly/uLnx50C5Lyi

SourceBio International PLC (AIM:SBI) CEO Jay LeCoque joins Proactive for an update after hailing 'strong support' from shareholders after yesterday's AGM: ow.ly/hup950Jz3qw

Executive Chairman of SourceBio International Plc, Jay LeCoque, takes investors through its trading recent update: ow.ly/11Wq50JyUBf #investing #shares #voxmarkets

Dr Tom Burr, Chief Scientific Officer for Source BioScience, will be speaking at this year’s @InvestMidlands on Friday March 25. The full-day conference will be packed with insight, analysis and original research. Click for more information: ow.ly/xvpO50Iob9S

*Register* Jay LeCoque, Executive Chairman, and Tony Ratcliffe, Chief Financial Officer, will provide a live presentation relating to the Company’s full year results on Tuesday 5 April at 4.45 pm (BST). Register today: ow.ly/T5LJ50IpWJ1

SourceBio is assembling an express shipment of laboratory and medical consumables, laboratory equipment and ancillary supplies to assist the people of Ukraine, with a separate commitment of £100,000 of cash funding to secure the delivery of trauma kits: ow.ly/YAIJ50IfRyE

SourceBio International completes strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms. Find out more: ow.ly/QHWg50IcvEH

SourceBio International plc notes an online article published by Which? titled ‘The best cheap day two Covid tests for travel’ that recommends SourceBio as the best provider of day two travel COVID-19 PCR testing. Find out more: ow.ly/qnbY50Gw0qp #SBI

*Join Today* Executive Chairman, Jay LeCoque and Tony Ratcliffe, Chief Financial Officer as they present #SBI interim results live to investors today at 4:30pm BST. Register now: ow.ly/HoMP50GhTqS #SBI #investing #capitalmarkets #stockmarkets

SourceBio International plc, notes the announcement made on Friday, 17 September 2021, by Grant Shapps, the Secretary of State for Transport, regarding planned changes to England's international travel rules and COVID-19 testing requirements. Find out more:ow.ly/U3D250GcKfp

SourceBio International plc #SBI announces that its Unaudited Half Year Results for the six months ended 30 June 2021 will be announced on Tuesday, 28 September 2021. Find out more: ow.ly/ppcL50FRvPS

SourceBio International plc #SBI provides a trading update for the half year ended 30 June 2021 confirming considerable growth in both revenues and EBITDA year-on-year. Find out more: ow.ly/GNeg50FEiKC

SourceBio International plc (AIM: SBI) provides an update to shareholders ahead of its Annual General Meeting (“AGM”) which will be held at 1pm today. Find out more: ow.ly/2c1p50F9r3T

SourceBio International #SBI has been added to the UK Government’s approved list as a private provider of day two and day eight (“D2/D8”) coronavirus testing for all international arrivals. Find out more: ow.ly/ScQD50ER1p8

SourceBio International #SBI announces that it has been successful with its tender for the Lot 4 Framework Agreement under Public Health England’s (“PHE”) National Microbiology Framework to provide its Clinical Laboratory Diagnostic Testing Services ow.ly/tiz550ER017

SourceBio International plc #SBI Annual Report and Accounts for the year ended 31 December 2020 and the Notice of the 2021 Annual General Meeting have been published. Find out more: ow.ly/6onp50EMTYR